533 related articles for article (PubMed ID: 32669459)
21. Standard versus biofilm antimicrobial susceptibility testing to guide antibiotic therapy in cystic fibrosis.
Waters V; Ratjen F
Cochrane Database Syst Rev; 2017 Oct; 10(10):CD009528. PubMed ID: 28981972
[TBL] [Abstract][Full Text] [Related]
22. Standard versus biofilm antimicrobial susceptibility testing to guide antibiotic therapy in cystic fibrosis.
Waters V; Ratjen F
Cochrane Database Syst Rev; 2015 Mar; (3):CD009528. PubMed ID: 25741986
[TBL] [Abstract][Full Text] [Related]
23. Standard versus biofilm antimicrobial susceptibility testing to guide antibiotic therapy in cystic fibrosis.
Smith S; Waters V; Jahnke N; Ratjen F
Cochrane Database Syst Rev; 2020 Jun; 6(6):CD009528. PubMed ID: 32520436
[TBL] [Abstract][Full Text] [Related]
24. The Small RNA ErsA Plays a Role in the Regulatory Network of Pseudomonas aeruginosa Pathogenicity in Airway Infections.
Ferrara S; Rossi A; Ranucci S; De Fino I; Bragonzi A; Cigana C; Bertoni G
mSphere; 2020 Oct; 5(5):. PubMed ID: 33055260
[TBL] [Abstract][Full Text] [Related]
25. Standard versus biofilm antimicrobial susceptibility testing to guide antibiotic therapy in cystic fibrosis.
Waters V; Ratjen F
Cochrane Database Syst Rev; 2012 Nov; 11():CD009528. PubMed ID: 23152277
[TBL] [Abstract][Full Text] [Related]
26. Airway biofilms: implications for pathogenesis and therapy of respiratory tract infections.
Kobayashi H
Treat Respir Med; 2005; 4(4):241-53. PubMed ID: 16086598
[TBL] [Abstract][Full Text] [Related]
27. Combination antibiotic susceptibility of biofilm-grown Burkholderia cepacia and Pseudomonas aeruginosa isolated from patients with pulmonary exacerbations of cystic fibrosis.
Dales L; Ferris W; Vandemheen K; Aaron SD
Eur J Clin Microbiol Infect Dis; 2009 Oct; 28(10):1275-9. PubMed ID: 19575248
[TBL] [Abstract][Full Text] [Related]
28. The Nitrite Transporter Facilitates Biofilm Formation via Suppression of Nitrite Reductase and Is a New Antibiofilm Target in Pseudomonas aeruginosa.
Park JS; Choi HY; Kim WG
mBio; 2020 Jul; 11(4):. PubMed ID: 32636243
[TBL] [Abstract][Full Text] [Related]
29. Co-culture models of Pseudomonas aeruginosa biofilms grown on live human airway cells.
Moreau-Marquis S; Redelman CV; Stanton BA; Anderson GG
J Vis Exp; 2010 Oct; (44):. PubMed ID: 20972407
[TBL] [Abstract][Full Text] [Related]
30. Formation of hydroxyl radicals contributes to the bactericidal activity of ciprofloxacin against Pseudomonas aeruginosa biofilms.
Jensen PØ; Briales A; Brochmann RP; Wang H; Kragh KN; Kolpen M; Hempel C; Bjarnsholt T; Høiby N; Ciofu O
Pathog Dis; 2014 Apr; 70(3):440-3. PubMed ID: 24376174
[TBL] [Abstract][Full Text] [Related]
31. Phenotypic and Genotypic Adaptations in Pseudomonas aeruginosa Biofilms following Long-Term Exposure to an Alginate Oligomer Therapy.
Oakley JL; Weiser R; Powell LC; Forton J; Mahenthiralingam E; Rye PD; Hill KE; Thomas DW; Pritchard MF
mSphere; 2021 Jan; 6(1):. PubMed ID: 33472983
[TBL] [Abstract][Full Text] [Related]
32. Anaerobic metabolism and quorum sensing by Pseudomonas aeruginosa biofilms in chronically infected cystic fibrosis airways: rethinking antibiotic treatment strategies and drug targets.
Hassett DJ; Cuppoletti J; Trapnell B; Lymar SV; Rowe JJ; Yoon SS; Hilliard GM; Parvatiyar K; Kamani MC; Wozniak DJ; Hwang SH; McDermott TR; Ochsner UA
Adv Drug Deliv Rev; 2002 Dec; 54(11):1425-43. PubMed ID: 12458153
[TBL] [Abstract][Full Text] [Related]
33. Pseudomonas aeruginosa biofilm formation in the cystic fibrosis airway.
Moreau-Marquis S; Stanton BA; O'Toole GA
Pulm Pharmacol Ther; 2008 Aug; 21(4):595-9. PubMed ID: 18234534
[TBL] [Abstract][Full Text] [Related]
34. Low-Dose Nitric Oxide as Targeted Anti-biofilm Adjunctive Therapy to Treat Chronic Pseudomonas aeruginosa Infection in Cystic Fibrosis.
Howlin RP; Cathie K; Hall-Stoodley L; Cornelius V; Duignan C; Allan RN; Fernandez BO; Barraud N; Bruce KD; Jefferies J; Kelso M; Kjelleberg S; Rice SA; Rogers GB; Pink S; Smith C; Sukhtankar PS; Salib R; Legg J; Carroll M; Daniels T; Feelisch M; Stoodley P; Clarke SC; Connett G; Faust SN; Webb JS
Mol Ther; 2017 Sep; 25(9):2104-2116. PubMed ID: 28750737
[TBL] [Abstract][Full Text] [Related]
35. Sodium nitrite blocks the activity of aminoglycosides against Pseudomonas aeruginosa biofilms.
Zemke AC; Gladwin MT; Bomberger JM
Antimicrob Agents Chemother; 2015; 59(6):3329-34. PubMed ID: 25801569
[TBL] [Abstract][Full Text] [Related]
36. Mucoid Pseudomonas aeruginosa Can Produce Calcium-Gelled Biofilms Independent of the Matrix Components Psl and CdrA.
Jacobs HM; O'Neal L; Lopatto E; Wozniak DJ; Bjarnsholt T; Parsek MR
J Bacteriol; 2022 May; 204(5):e0056821. PubMed ID: 35416688
[TBL] [Abstract][Full Text] [Related]
37. Cephalosporin nitric oxide-donor prodrug DEA-C3D disperses biofilms formed by clinical cystic fibrosis isolates of Pseudomonas aeruginosa.
Soren O; Rineh A; Silva DG; Cai Y; Howlin RP; Allan RN; Feelisch M; Davies JC; Connett GJ; Faust SN; Kelso MJ; Webb JS
J Antimicrob Chemother; 2020 Jan; 75(1):117-125. PubMed ID: 31682251
[TBL] [Abstract][Full Text] [Related]
38. Impairment of Pseudomonas aeruginosa Biofilm Resistance to Antibiotics by Combining the Drugs with a New Quorum-Sensing Inhibitor.
Furiga A; Lajoie B; El Hage S; Baziard G; Roques C
Antimicrob Agents Chemother; 2015 Dec; 60(3):1676-86. PubMed ID: 26711774
[TBL] [Abstract][Full Text] [Related]
39. Psl Produced by Mucoid
Jones CJ; Wozniak DJ
mBio; 2017 Jun; 8(3):. PubMed ID: 28634241
[TBL] [Abstract][Full Text] [Related]
40. Secondary messenger signalling influences Pseudomonas aeruginosa adaptation to sinus and lung environments.
Ruhluel D; Fisher L; Barton TE; Leighton H; Kumar S; Amores Morillo P; O'Brien S; Fothergill JL; Neill DR
ISME J; 2024 Jan; 18(1):. PubMed ID: 38647527
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
